Nitroxyl
(ODUCDPQEXGNKDN-UHFFFAOYSA-N)
Structure
- SMILES
- N=O
- Molecular Formula:
- HNO
- Molecular Weight:
- 31.014
- Log P:
- 0.4313
- Hydrogen Bond Acceptor:
- 2
- Hydrogen Bond Donor:
- 1
- TPSA:
- 40.92
- CAS Number(s):
- 11129-69-4; 14332-28-6
Synonym(s)
1.
Nitroxyl
External Link(s)
| PubChem Compound | 945 |
| ChEBI | 84879 |
| KEGG | cpd:C20937 |
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Device Failure | FAERS: 30 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 2 | Cardiac Arrest | FAERS: 17 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 3 | Device malfunction | FAERS: 16 | US FAERS | |
| 4 | General physical health deterioration | FAERS: 13 | US FAERS | |
| 5 | Occupational exposure to product | FAERS: 12 | US FAERS | |
| 6 | Product use issue | FAERS: 11 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 7 | Drug ineffective for unapproved indication | FAERS: 9 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 8 | Medication Error | FAERS: 8 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 9 | No adverse event | FAERS: 8 | US FAERS | |
| 10 | Drug ineffective | FAERS: 7 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 11 | Medical device complication | FAERS: 7 | US FAERS | |
| 12 | Pneumothorax | FAERS: 7 | US FAERS | |
| 13 | Hypotension | FAERS: 6 | US FAERS | |
| 14 | Bradycardia | FAERS: 5 | US FAERS | |
| 15 | Headache | FAERS: 5 | US FAERS | |
| 16 | Nausea | FAERS: 5 | US FAERS | |
| 17 | Respiratory Failure | FAERS: 5 | US FAERS | |
| 18 | Sepsis | FAERS: 5 | US FAERS | |
| 19 | Hypoxia | FAERS: 4 | US FAERS | |
| 20 | Pulmonary Embolism | FAERS: 4 | US FAERS | |
| 21 | Chest discomfort | FAERS: 3 | US FAERS | |
| 22 | Dizziness | FAERS: 3 | US FAERS | |
| 23 | Pneumonia | FAERS: 3 | US FAERS | |
| 24 | Pulmonary Hypertension | FAERS: 3 | US FAERS | |
| 25 | Pulmonary arterial pressure increased | FAERS: 3 | US FAERS | |
| 26 | Right ventricular failure | FAERS: 3 | US FAERS | |
| 27 | Shock | FAERS: 3 | US FAERS | |
| 28 | Ventricular Fibrillation | FAERS: 3 | US FAERS | |
| 29 | Wrong drug administered | FAERS: 3 | US FAERS | |
| 30 | Device alarm issue | FAERS: 2 | US FAERS | |
| 31 | Device leakage | FAERS: 2 | US FAERS | |
| 32 | Disease Progression | FAERS: 2 | US FAERS | |
| 33 | Disseminated Intravascular Coagulation | FAERS: 2 | US FAERS | |
| 34 | Drug administered to patient of inappropriate age | FAERS: 2 | US FAERS | |
| 35 | Drug administration error | FAERS: 2 | US FAERS | |
| 36 | Drug delivery system malfunction | FAERS: 2 | US FAERS | |
| 37 | Endocarditis | FAERS: 2 | US FAERS | |
| 38 | Intestinal Perforation | FAERS: 2 | US FAERS | |
| 39 | Neonatal disorder | FAERS: 2 | US FAERS | |
| 40 | Neonatal respiratory arrest | FAERS: 2 | US FAERS | |
| 41 | Neonatal respiratory failure | FAERS: 2 | US FAERS | |
| 42 | Pain | FAERS: 2 | US FAERS | |
| 43 | Product use in unapproved indication | FAERS: 2 | US FAERS | |
| 44 | Rebound effect | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 45 | Therapeutic response unexpected | FAERS: 2 | US FAERS | |
| 46 | Therapy cessation | FAERS: 2 | US FAERS | |
| 47 | Therapy non-responder | FAERS: 2 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 48 | Thrombocytopenia | FAERS: 2 | US FAERS | |
| 49 | Unresponsive to stimuli | FAERS: 2 | US FAERS | |
| 50 | Withdrawal of life support | FAERS: 2 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 51 | Wrong technique in device usage process | FAERS: 2 | US FAERS | |
| 52 | Accidental exposure to product | FAERS: 1 | US FAERS | |
| 53 | Accidental exposure | FAERS: 1 | US FAERS | |
| 54 | Accidental overdose | FAERS: 1 | US FAERS | |
| 55 | Acute kidney injury | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 56 | Alveolar capillary dysplasia | FAERS: 1 | US FAERS | |
| 57 | Anaphylactic shock | FAERS: 1 | US FAERS | |
| 58 | Anoxia | FAERS: 1 | US FAERS | |
| 59 | Asthenia | FAERS: 1 | US FAERS | |
| 60 | Atrial Fibrillation | FAERS: 1 | US FAERS | |
| 61 | Bacterial sepsis | FAERS: 1 | US FAERS | |
| 62 | Blood pH decreased | FAERS: 1 | US FAERS | |
| 63 | Brain Death | FAERS: 1 | US FAERS | |
| 64 | Bronchitis | FAERS: 1 | US FAERS | |
| 65 | Bronchopulmonary Dysplasia | FAERS: 1 | US FAERS | |
| 66 | Complication of device insertion | FAERS: 1 | US FAERS | |
| 67 | Dermatomyositis | FAERS: 1 | US FAERS | |
| 68 | Device connection issue | FAERS: 1 | US FAERS | |
| 69 | Device deployment issue | FAERS: 1 | US FAERS | |
| 70 | Device information output issue | FAERS: 1 | US FAERS | |
| 71 | Device use error | FAERS: 1 | US FAERS | |
| 72 | Drug exposure during pregnancy | FAERS: 1 | US FAERS | |
| 73 | Dysarthria | FAERS: 1 | US FAERS | |
| 74 | Epistaxis | FAERS: 1 | US FAERS | |
| 75 | Erythema | FAERS: 1 | US FAERS | |
| 76 | Hepatic congestion | FAERS: 1 | US FAERS | |
| 77 | Idiopathic Pulmonary Fibrosis | FAERS: 1 | US FAERS | |
| 78 | Incorrect dose administered by device | FAERS: 1 | US FAERS | |
| 79 | Influenza | FAERS: 1 | US FAERS | |
| 80 | Malaise | FAERS: 1 | US FAERS | |
| 81 | Metabolic acidosis | FAERS: 1 | US FAERS | |
| 82 | Oliguria | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 83 | Post procedural complication | FAERS: 1 | US FAERS | |
| 84 | Procedural complication | FAERS: 1 | US FAERS | |
| 85 | Product quality issue | FAERS: 1 | US FAERS | |
| 86 | Product used for unknown indication | FAERS: 1 | US FAERS | |
| 87 | Pulmonary hypertensive crisis | FAERS: 1 | US FAERS | |
| 88 | Respiratory tract infection viral | FAERS: 1 | US FAERS | |
| 89 | Right Ventricular Dysfunction | FAERS: 1 | US FAERS | |
| 90 | Right Ventricular Hypertrophy | FAERS: 1 | US FAERS | |
| 91 | Septic Shock | FAERS: 1 | US FAERS | |
| 92 | Stenotrophomonas infection | FAERS: 1 | US FAERS | |
| 93 | Subcutaneous Emphysema | FAERS: 1 | US FAERS | |
| 94 | Tachycardia | FAERS: 1 | US FAERS | |
| 95 | Therapeutic product effect incomplete | FAERS: 1 | US FAERS | |
| 96 | Therapeutic product ineffective for unapproved indication | FAERS: 1 | US FAERS | |
| 97 | Throat irritation | FAERS: 1 | US FAERS | |
| 98 | Toxic Shock Syndrome | FAERS: 1 | US FAERS | |
| 99 | Wrong technique in product usage process | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 100 | Product complaint | Canada Vigilance: 1 | Canada Vigilance | |
| 101 | Product packaging issue | Canada Vigilance: 1 | Canada Vigilance |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120269
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.